Posts tagged HDFC Sec
| ROLLOVER ANALYSIS: REMAIN BULLISH AND USE ANY CORRECTIONS TO ACCUMULATE LONG POSITIONS WITH SL OF 18000: HDFC Sec | |
| Company: | Model Portfolio |
| Brokerage: | HDFC Sec |
| Date of report: | May 26, 2023 |
| Type of Report: | Techno-Funda |
| Recommendation: | Buy |
| Upside Potential: | 100% |
| Summary: | Higher open Interest in the Nifty Futures’ as compared to last series (long rollover), Lower stock Futures’ Open Interest (compared to all time highs) despite sharp rise in the Nifty from March 2023 lows, FIIS long to short ratio in the Index Futures at 1.36 (Long build up by FIIS in the Index Futures segment) and aggressive Put writing at 18000 levels indicates that downside is limited in the Nifty and one should continue to remain optimistic for the June series. |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Model Portfolio |
| Bajaj Finance Correction offers an attractive entry; upgrade to ADD for Target Price INR 6,700: HDFC Sec | |
| Company: | Bajaj Finance |
| Brokerage: | HDFC Sec |
| Date of report: | January 28, 2023 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 16% |
| Summary: | Bajaj Finance (BAF) delivered a strong operating performance, with steady NIMs in a rising interest rate and strong AUM growth (+27% YoY) environment. |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Bajaj Finance |
| Equity MF Performance Summary by HDFC Securities | |
| Company: | Mutual Funds |
| Brokerage: | HDFC Sec |
| Date of report: | January 13, 2023 |
| Type of Report: | Model Portfolio |
| Recommendation: | Buy |
| Upside Potential: | 100% |
| Summary: | Equity MF Performance Summary by HDFC Securities |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Mutual Funds |
| Buy Gujarat Themis Biosyn for target price of Rs 909: HDFC Securities | |
| Company: | Gujarat Themis Biosyn |
| Brokerage: | HDFC Sec |
| Date of report: | January 2, 2023 |
| Type of Report: | Initiating Coverage |
| Recommendation: | Buy |
| Upside Potential: | 17% |
| Summary: | Prior to FY20, company was engaged in contract manufacturing of Rifamycin S for Lupin. During FY20, management decided to change business model from contract manufacturing to manufacturing and sales model; as a result the company’s operating profitability has significantly improved. Company had reported robust numbers over FY20-22 |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Gujarat Themis Biosyn |
| Latest List Of High Dividend Yield Stocks (28 December 2022) By HDFC Sec | |
| Company: | Model Portfolio |
| Brokerage: | HDFC Sec |
| Date of report: | December 28, 2022 |
| Type of Report: | Model Portfolio |
| Recommendation: | Buy |
| Upside Potential: | 14.6% |
| Summary: | table of companies (CNX 500 stocks) that offer dividend yield of 3.00% and above |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | High Dividend Yield, Model Portfolio |
| Devyani International riding on the strong business momentum in core brand business. Buy for target of Rs 220: HDFC Securities | |
| Company: | Devyani International Ltd |
| Brokerage: | HDFC Sec |
| Date of report: | November 30, 2022 |
| Type of Report: | Initiating Coverage |
| Recommendation: | Buy |
| Upside Potential: | 18% |
| Summary: | A strong recovery in the out-of-home consumption, rising traction for branded products, aggressive store expansion plans, value proposition through an innovated menu and widening delivery reach will help DIL’s revenues clock a CAGR of 36% over FY22-24E (~23% increase due to store count) |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Devyani International Ltd |
| ROLLOVER ANALYSIS. REMAIN BULLISH AND USE ANY CORRECTIONS TO ACCUMULATE LONG POSITIONS WITH SL OF 18000: HDFC Sec | |
| Company: | Model Portfolio |
| Brokerage: | HDFC Sec |
| Date of report: | November 25, 2022 |
| Type of Report: | Techno-Funda |
| Recommendation: | Buy |
| Upside Potential: | 100% |
| Summary: | To Sum it up, Lower stock Futures’ Open Interest (compared to all time highs), Lower Open Interest in the Nifty Futures’ as compared to last 17 year average OI of 2.08 Cr shares despite Nifty near all time highs, FIIS long to short ratio in the Index Futures at 3.28 (Aggressive Long build up by FIIS in the Index Futures segment), aggressive Put writing at 18000 levels and strong recovery in the global markets from the recent lows indicates that downside is limited in the Nifty and one should remain optimistic for the December series also. |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | technical analysis |
| AXIS Bank is on track to deliver steady performance. Buy for target price of Rs 1195 (35% upside): HDFC Securities | |
| Company: | Axis Bank |
| Brokerage: | HDFC Sec |
| Date of report: | November 25, 2022 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 35% |
| Summary: | AXSB finally seems to be on track to deliver steady performance with lower shocks. While the bank is on track to deliver ~14-15% RoE over the next couple of years, we argue that enhanced productivity and gradual exercising of pricing power in chosen segments could drive sustained medium-term RoEs. We argue for a gradual convergence in valuation multiples with ICICIBC |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Axis Bank |
| Buy HG Infra for target price of Rs 1013. Execution pick-up will drive further rerating: HDFC Sec | |
| Company: | HG Infra |
| Brokerage: | HDFC Sec |
| Date of report: | November 11, 2022 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 87% |
| Summary: | The company plans to monetise four HAM projects at a ~40% premium to book value of INR 3.5bn invested equity by Mar’23. Given robust order inflow and strong execution, we maintain BUY, with an increased TP of INR 1,013 (14x Sep-24E EPS) to factor in a higher level of execution and better EBITDA margin |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | HG Infra |
| AGS Transact Technologies is a BUY for 48% Upside: HDFC Securities | |
| Company: | AGS Transact Technologies |
| Brokerage: | HDFC Sec |
| Date of report: | September 23, 2022 |
| Type of Report: | Initiating Coverage |
| Recommendation: | Buy |
| Upside Potential: | 48% |
| Summary: | AGS Transact Technologies Ltd (AGS) is the second largest ATM outsourcing and cash management player in India, with a 15/30% market share. The company has been able to sustain the impact of COVID-19 (ATM transactions declined by ~30%), supported by its strong and sticky relationship with top Indian banks and upward revision in interchange fees by ~14% by the regulator |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | AGS Transact Technologies |